A new human Duffy blood group specificity defined by a murine monoclonal antibody. Immunogenetics and association with susceptibility to Plasmodium vivax by unknown
A NEW HUMAN DUFFY BLOOD GROUP SPECIFICITY
DEFINED BY A MURINE MONOCLONAL ANTIBODY
Immunogenetics and Association with Susceptibility to Plasmodium vivax
BY MARGARET E. NICHOLS,* PABLO RUBINSTEIN,* JOHN BARNWELL,t
SANTIAGO RODRIGUEZ DE CORDOBA,* AND RICHARD E. ROSENFIELD*
From the *LindsleyF. Kimball Research Institute of The New York Blood Center,
New York 10021; and the *New York University School ofMedicine, Department ofMedical
and Molecular Parasitology, New York, 10016
The Duffy blood group system of human erythrocytes comprises a membrane
glycoprotein recently characterized by immunoprecipitation techniques (1) . It is
a polymorphic system that includes determinants for five alloantigens, two of
which are Mendelian alleles (Fya and Fyb) (2, 3) . A null genotype, designated
Fy(ab-) (4), lacks the expression of both Fya and Fyb , and is inherited as a third
allele of the series . Homozygous Fy(a-b-) red cells, however, also lack expression
of the Fy3 (5) antigen, which is present on all other Duffy types . Fy4 (6) occurs
on almost all samples ofFy(ab-), but the expression isweakon some . In addition
Fy4 is occasionally found on red cells of Fy(a+b'), so that its exact Duffy status is
not in perfect agreement with the absence of both Fya and Fyb (7) . Fy5 (8)
resembles Fy3 but is also absent from Rh-null red cells regardless of their other
Duffy types .
These five specificities are inherited en bloc butthey differ in their susceptibility
to proteolytic enzyme treatment ; the high frequency antigens Fy3, Fy4, and Fy5
being resistant to the effects of chymotrypsin, ficin, and papain, while Fya and
Fyb are completely destroyed by these enzymes (7) . Duffy maps to chromosome
1 (9) (i.e ., is syntenic to Rh), which may be related to the peculiar absence of Fy5
on Rh-null cells .
Interest in the Duffy system has been considerable since the demonstration by
Miller et al . (10) that Fy(a-b-) erythrocytes are resistant to the penetration of
Plasmodium knowlesi merozoites in vitro (10), and that the red cells of individuals
of that type are not infected by Plasmodium vivax (11) even in regions of very
high endemism (12, 13). Confirmation of the role of Duffy molecules in the
penetration of merozoites has been obtained by specific though partial blocking
of the P. knowlesi receptor function by alloantibody to Fya (10) .
We have prepared a murine monoclonal antibody, anti-Fy6, that reacts with
all human red cells except for those of the Fy(ab-) phenotype . The specificity
defined by anti-Fy6 differs significantly from others previously identified in the
Duffy system . In this report we show that Fy6 is not only characteristic of Duffy,
but is related to the penetration of red cells by P . vivax merozoites.
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Monoclonal Anti-Duffy (Anti-Fy6).
￿
Originally designated NYBC-BG6, anti-Fy6 was ob-
tained essentially according to Kohler and Milstein (14) using a protocol described
previously (15) . Briefly, pooled human red cells, used as immunogen, were injected
intraperitoneally into BALB/c mice, and the spleen cells from an immunized mouse were
fused with NSO/1 mouse myeloma cells . Primary fusion well culture supernatants were
tested for antibody activity using conventional saline, enzyme, and indirect antiglobulin
techniques (16) . The anti-Fy6-producing cell line resulted from a colony, cloned three
times, that has remained stable for well over a year . Fresh, fully typed human red cells,
and liquid nitrogen-stored reconstituted human and nonhuman primate red cells were
used to define specificity . Indirect antiglobulin tests of monoclonal anti-Fy6-coated red
cells were performed with a locally prepared rabbit anti-mouse IgG reagent exhaustively
preadsorbed with human red cells . Similar tests with human alloantibody coated cells
were performed with a locally prepared monoclonal mouse anti-human IgG reagent .
Immunoglobulin Class Determination . The immunoglobulin class and subclass were
identified by Ouchterlony immunodiffusion (17) using rabbit anti-mouse K and goat anti-
mouse a (Research Products International Corp., Mt . Prospect, IL), anti-mouse IgGI,
IgG2a, IgG2b, IgG3, IgM, and IgA (Miles Scientific, Naperville, IL) .
Alloantisera .
￿
Anti-Fy" and anti-Fyb reagents were purchased from Gamma Biologicals,
Inc . (Houston, TX) . Anti-Fy3 was kindly provided by Dr . W . L . Marsh of the New York
Blood Center .
Antibody Elution .
￿
For tests of red cells from nonhuman species, human alloantibodies
were isolated by adsorption onto positively reacting human cells and elution using ether
and heat .'
Enzyme Treatment of Red Cells.
￿
1% (vol/vol) red cell suspensions (10 8 cells/ml) were
incubated in each of the different enzyme solutions at 37°C, as described by Mason et al .
(18) . Neuraminidase (Clostridium perfringens, type X, purified, 160 U/mg protein), trypsin
(bovine pancreas, type XI, DPCC-treated), chymotrypsin (bovine pancreas, type VII,
TLCK-treated) crude ficin, and trypsin inhibitor (soybean type 1-S) were all obtained
from Sigma Chemical Co., St . Louis, MO, while papain (African papaya) was from
Calbiochem Behring Corp ., San Diego, CA . All enzymes were used in phosphate (0.015
M, pH 7 .3)-buffered physiological saline solution (PBS) neuraminidase at a concentration
of 100 mU/ml, and the others at 1 mg/ml . Neuraminidase-treated red cells were
agglutinated by Arachis hypogoea lectin indicating that they had been T activated (19) .
Freshly chymotrypsm-treated red cells were incubated for 10 min at room temperature
in PBS containing 10-8 M phenylmethylsulfonyl fluoride (PMSF)2 and 5% 2-propanol .
Freshly trypsin-treated red cells were incubated for 10 min at room temperature in
soybean trypsin inhibitor solution . All enzyme-treated cells were washed three times in
PBS and suspended in PBS for use in serological tests .
Purification and Measurement ofMonoclonal Antibody Protein Concentration .
￿
The mono-
clonal antibody was precipitated from ascites fluid with an equal volume of45% saturated
ammonium sulfate. The precipitate was dissolved in PBS, dialyzed against 20 mM Tris,
10 mM NaCl (pH 8.6) and passed through a DEAE Sephacel column (Pharmacia Fine
Chemicals, Piscataway, NJ) equilibrated with 20mM Tris, 10 mM NaCl buffer (pH 8.6) .
Adsorbed proteins were eluted with a 20-200 mM NaCl gradient. Fractions were tested
for anti-Duffy activity, and the antibody was found to elute as a single, narrow peak . The
IgG content of this peak was measured both by absorbance at 280 nm, and by ELISA
blocking using a highly purified mouse IgGl myeloma protein as standard (20) .
Radiolabeling .
￿
100 til of purified monoclonal antibody (215,ug) was labeled by solid-
phase radioiodination using Iodo-Gen (Pierce Chemical Co ., Rockford, IL), and freed of
unbound iodine by filtration through Sephadex G-10, followed by dialysis against PBS at
4°C overnight . The specific activity of the labeled antibody preparation was determined
by measuring both TCA-precipitable radioactivity in a gamma counter, and IgG concen-
' Marsh, W . L ., cited in Widmann (16) .
'Abbreviations used in this paper: HRP, horseradish peroxidase ; PMSF, phenylmethylsulfonyl
fluoride .778
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tration was determined by ELISA blocking assay (20) . Specifically binding antibody in the
labeled protein as a fraction of the total radioactivity was measured by adsorption with an
excess of cells of the Fy(a+b+ ), Fy(a+b-), Fy(a-b'), and Fy(ab- ) types in the presence and
in the absence of 2,500-10,000-fold excess of unlabeled anti-Fy6 .
Assay of Antibody Binding by Red Cells of Different Duffy Types.
￿
Fresh red blood cells
were washed four times in PBS containing 10% (vol/vol) indifferent murine Freund's
adjuvant-induced ascites fluid, and resuspended in the same solution to a cell count of
exactly 10 8 cells/ml, determined electronically (Coulter S + IV, Coulter Electronics,
Miami, FL) . This suspension was distributed in 0.5 ml volumes, centrifuged, and 0.4 ml
of supernatant was removed without disturbing the pellets . The tubes containing red cell
pellets were assembled in sets of duplicates for each cell type and each antibody concen-
tration . The labeled antibody displayed 4.2 x 106 dpm/Fg IgG which, assuming 150 kD
molecular mass, corresponded to 6 .3 x 10 5 dpm/pM . 1-ml aliquots of labeled antibody
solutions, containing respectively 2.4, 1 .8, 1 .2, and 0.6 pM in PBS with 10% murine
ascites, were added . Reaction mixtures were incubated at 37'C for 1 h, and then overnight
at 4 °C with occasional mixing . Free antibody was determined by counting the radioactivity
in 0 .1 ml of supernatant fluid and correcting for the total reaction volume and mean
corpuscular volume of the reacted red cells . Bound antibody was computed as the
difference between the total antibody applied and the free antibody measured . This value
was -10% greater than the counts on the respective adsorbing red cells separated by
passage through a 4:1 mixture of di-n-butyl and di-nonyl phthalate (Eastman Kodak
Company, Rochester, NY) . By either method, Fy(ab-) red cells were found to bind <3%
of applied antibody . Nevertheless, the uptake of Fy6 to Fy(ab-) cells was subtracted from
the uptake of Fy6+ phenotypes, after which the reciprocal of the moles ofbound antibody
was plotted against the reciprocal of the moles of free antibody (21) . For each of the four
Fy6+ phenotypes, the data plotted linearly, and least squares point-estimates of slope and
intercept were calculated directly . The reciprocal of the y-intercept thus corresponds to
maximal antibody bound in the presence of infinite free antibody, while intercept divided
by slope (correcting for volume) corresponds to K., the constant of binding of the antigen-
antibody reaction equilibrium . A one-to-one correspondence ofbound antibody to antigen
was assumed to calculate antigen sites from pM, the point ofmaximum bound antibody.
Detection ofDuffyMolecules in Western Blots .
￿
Red cell ghosts were prepared by hypotonic
lysis with six volumes of 10mM Tris HCI (pH 7.4) containing I mM PMSF for 30 min at
4°C . After several washes in the hypotonic buffer to remove all residual hemoglobin, the
membranes were extracted in 1 % deoxycholate (DOC) for 30 min at 4'C and insoluble
materials were removed by centrifugation at 12,000 g . Equal volumes of supernatant were
mixed with 0.1 M Tris (pH 6.8) containing 10% SDS, 10% glycerol, and 0.01% bromo-
phenol blue, and boiled for 3 min . 100 ul was loaded on a 4-12% gradient SDS-
polyacrylamide gel using a 3% stacking gel, and electrophoresed with the discontinuous
buffer system of Laemmli (22) . Molecular weight standards (Pharmacia Fine Chemicals,
Piscataway, NJ) were run in parallel . The separated molecular species were electroblotted
onto nitrocellulose membranes using a trans-blot cell (Bio-Rad Laboratories, Richmond,
CA) for 7-9 h at 4°C and 250 mA with Tris glycine buffer (20 mM Tris, 192 mM glycine)
containing 20% (by volume) methanol . The membranes were blocked against nonspecific
adsorption of labeled antibody by overnight incubation at 4°C in 50 mM Tris (pH 8.0)
containing 100 mM sodium chloride, 20% FCS, and 0.05% sodium azide . The blots were
then incubated overnight in anti-Fy6-containing culture supernatant diluted 1 :2 in 50
mM Tris buffer (pH 8.0) containing 100 mM sodium chloride and 0.05% Tween 20 .
This antibody solution (^-2 .5 wg ofantibody immunoglobulin per milliliter) had an indirect
antiglobulin titer value of 1 :1,000 . Following three 10-min washes in Tris buffer contain-
ing 1% BSA, the blots were incubated for 2 h at room temperature with horseradish
peroxidase (HRP)-conjugated rabbit anti-mouse IgG and diluted 1 :1,000 in Tris/BSA
buffer . Blots were washed three times in Tris/BSA, and HRP color development was
obtained by the addition of 4-chloro-l-napthol substrate .
Erythrocyte Invasion by P . vivax.
￿
Squirrel monkeys undergoing synchronous infection
with P. vivax (Belem) provided red cells infected with trophozoite or early schizontNICHOLS ET AL .
TABLE I
Reactions ofNYBC-BG6 with Various Human Red Cell Samples
Results and Discussion
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Human and murine antisera were tested with 4% red cell suspensions by the indirect antiglobulin
method.
* Data from Colledge et al . (8) .
$ These red cells carry a weak Fyb antigen and support only one-fourth the titration endpoint
obtained with other Fy(b+) samples.
$ Amorphic type ; homozygous for amorphic alleles at the Rh locus.
Regulator type; homozygous for inhibitor genes unlinked to the Rh locus.
parasites (31) . Platelets and leucocytes were separated by passage through glass bead and
CFI l -cellulose columns after admixture with ADP to induce platelet aggregation . After
the red cell suspension was centrifuged against a 54% percoll cushion, the parasitized cells
were recovered at the interface with a purity of85-90% . The target human erythrocytes,
obtained from the interface of a 65% percoll cushion, were then added to the parasitized
cells in a ratio of 5:1 or 10:1, depending on the degree of parasitemia. Invasion was
allowed to proceed for 8-10 h before harvesting, preparing Giemsa-stained films, and
counting 2,000 cells under light microscopy to determine the proportion of cells contain-
ing ring-stage parasites .
Fyb Duff y Specificity.
￿
The presence of anti-Duffy antibody in an initial super-
natant was confirmed by testing it with a panel of selected red cells, all of which
were agglutinated, except for those of type Fy(ab- ) . After cloning, the IgGIic
monoclonal antibody, designated NYBC-BG6, was tested against a second panel
of selected erythrocytic blood groups and against the red cells of 500 random,
consecutive donors . Again, it only failed to react with all 22 examples ofFy(ab-)
individuals in these tests . Other tests to confirm specificity included cells that
lacked high frequency antigens; e.g ., Vel:-I,-2, Lu(a-b-), jk(a-b-), Oh, jr(a ),
Ge- , Tj(a- ), Hy- , jo(a- ), Wr(b-), U- , Ko, McLeod, and especially, cells of both
typesofRh null (23) . These tests are particularly important becauseof the Duffy-
Rh relationship disclosed by anti-Fy5, which fails to react not only with Fy(a-b- )
red cells but also with Fya+ or Fyb+ cells if they are Rh null (8) . Fy5 is thus an
interactive product distinct from all other Duffy blood group specificities . The
results, shown in Table I, indicate that the epitope recognized by the NYBC-
BG6 antibody is indeed within the Duffy system, with a distribution similar to
that of Fy3 .
As shown in Table 11, the reactivity of Fya, Fyb , and Fy6 are destroyed by
ficin, papain, and chymotrypsin, all of which actually enhance the reactivity of
the Fy3 antigen . Trypsin, which does not affect Fya, slightly reduces Fyb while
enhancing both Fy3 and Fy6 .
The Number ofFy6 Sites on Human Red Cells.
￿
A previous study (24) using
Blood type Anti-Fy' Anti-Fyb Anti-Fy3 Anti-Fy5* NYBC-BG6
Fy(A+b- ) + - + + +
Fy(a-b*) - + + + +
Fy(a+b+) + + + + +
Fy'Fy '* + + + + +
Fy(ab- ) - - - - -
Fy(ab+) Rh nulls - + + - +
Fy(a+b*) Rh nul1M + + + - +780
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TABLE II
Effect ofEnzyme Treatment of Red Blood Cells on Titer Values ofHuman Polyclonal
Anti-Fy°, -Fy°, and -Fy3 and Murine Monoclonal Anti-Fy6
Cells at 1% concentration were incubated with each enzyme solution at 37°C, washed and tested
as described in Table I .
* Human reagents were adsorbed with Fy(ab- ) neuraminidase treated red cells before testing to
remove their content of anti-T agglutinins .
Trypsin-treated red cells were incubated for 10 min at room temperature with I mg/ml soybean
trypsin inhibitor .
Erythrocytes were incubated for 2 h at 37°C with chymotrypsin, washed andincubated for 10 min
at room temperature in enzyme inhibitor(PMSF) .
quantitative immunoferritin electron microscopy suggested that normal adult
red cells of the Fy(a+b-) type have ^-13,300 Fya sites per cell, compared to about
6,900 siteson Fy(a'b+) heterozygous cells . Using a directly iodinated preparation
of anti-Fy6, the number of binding sites at equilibrium was estimated using
different concentrations of antibody and a constant number of red cells. The
antibody used in those assays was first shown to be highly active after iodination :
84-90% of theradioactivity was specifically removedby adsorption with Fy(a'b-),
Fy(a-b+) or Fy(a'b+) cells, and 95% of this binding was inhibited by an excess of
unlabeled anti-Fy6 . Binding data at equilibrium was obtained for the different
antibody concentrations and for cells of the four common Duffy types, and the
number of sites per cell was then calculated using a Langmuir adsorption
isotherm (21), as shown in Fig. l . The mean number of sites on Fy6 cells was
estimated at 12,200 ± 1,260 per cell, with amean bindingconstant at equilibrium
of 3 .1 (±0.22) X 108/M, with no visibleheterogeneityof binding . The differences
in point estimates for these values, obtained with erythrocytes of the three
positive types, Fy(a'''b-) Fy(a-b+), and Fy(a'b+), were quite small . We must yet,
however, define site density and Ko values with red cells known from genetic
studies to be heterozygous for the Fy6 epitope .
FIGURE 1 .
￿
Langmuir equilibrium adsorption studies of 121I-labeled anti-Fy6 mAb . Human
red cells of five different individuals were tested : Fy(a'b'),** and00 ; Fy(a'b-), ++ ; Fy(ab'),
XX ; and Fy(ab-) . The latter, not shown, adsorbed <3% of applied antibody . Duplicated
aliquots of 5 X 108red cells were incubated with 0.6, 1 .2, 1 .8, and 2 .4 pM of labeled anti-Fy6 .
Free antibody is based on mean dpm adjusted for both fluid volume and mean corpuscular
volume of the tested erythrocytes was subtracted from total antibody applied to obtain bound
antibody . However, mean antibody bound by Fy(ab- ) cells was considered nonspecific and
was subtracted from antibody bound by Fy6' red cells . For each of the four Fy6' cells, the
reciprocal of bound antibody (minus the nonspecific) was plotted against the reciprocal o£ free
antibody to obtain point estimates of intercept and slope . Assuming 150,000M, for antibody
and a one-to-one correspondence between bound antibody and antigen, numbers of antigen
sites per cell were calculated from the reciprocal of the intercept value . Theaverage constant
of binding at equilibrium (K.) was obtained by dividing the intercept value by the slope value .
Point estimates for each individual cell type are shown in inset . The line shown is based on
intercept and slope values derived from the mean values for sites per cell, and K .
Enzyme Tested pheno-
type
Human antisera*
Anti-Fy' Anti-Fy6 Anti-Fy3
Murine
anti-Fy6
None Fy(a'b') 16 16 512 1,024
Neuraminidase (10 U/ml) Fy(a'b') 16 16 512 2,048
Trypsin (1 mg/ml) Fy(a'b')$ 16 4 2,048 4,096
Chymotrypsin (1 mg/ml) Fy(a'b')l 0 0 2,048 0
Ficin (1 mg/ml) Fy(a'b') 0 0 2,048 0
Papain (1 mg/ml) Fy(a'b') 0 0 2,048 08
NICHOLS ET AL .
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FIGURE 2 .
￿
Western immunoblot analysis of anti-Fy6mAb. Electropho-
retically separated(SDS-PAGE) membrane proteins from red cells of the
four major Duffy types were blotted onto nitrocellulose membranes and
incubated overnight with anti-Fy6 mAb . A 1 :1,000 dilution of HRP-
conjugated rabbit anti-mouse IgG was used as second antibody . Colori-
metric identification of the bound mAb was obtained by the addition of
4-chloro-I-napthol . Molecular mass markers are indicated at left (kD) .
TABLE III
Summary ofDuffy/Anti-Duffy Reactions with Primate Red Cells
* Serologically weak positive .
x Data from current study.
Marsh, W . L . s
1 Barnwellj, M . E . Nichols, and P. Rubenstein, manuscript in preparation .
Primate
Common name Species
Human
Fy° Fyb
antisera
Fy3
for:
Fy5
Refer-
ence
Invasion
by P.
knowlsi
Refer-
ence
Invasion
byasvt
Refer-
ence
Murine
anti-Fy6#
Man Homo sapiens + 0 + + 5,7* + 1 + I 1 1 +
0 + + + 5, 7x + 27 + 11 1 +
+ + + + 5,7= + 10 + 11,13 +
0 0 0 0 5, 7t 0 t 0 11, 13 0
Great Apes
Gorilla Gorilla gorilla beringet 0 +* + + 25, 26 NT NT +*
Chimpanzee Pan troglodytes 0 + + 0 261 + 4 + 28 +
Gibbon Hylobates agilis 0 + + NT 261 + 4 + 30 +*
Old World monkeys
Rhesus Macaca mulatta 0 + + 0 261 + 1 0 29 0
Cynomolgus Macaca fascicularis 0 +* + 0 261 + 1 0 28 0
Baboon Papio sp . +* + + NT 25t + 28 NT 0
New World monkeys
Squirrel Saimiri sciureus 0 0 + NT Id + 1 + 28 1 +
Capuchin Cebus apella 0 0 + NT U 0 ; 0 28 1 0
Dourocoli Aolus trivirgatus 0 + + NT 261 + 1 + 32 +NICHOLS ET AL .
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Apparent Molecular Mass ofFy6 Protein .
￿
After Western blotting ofmembrane
proteins from Fy(a''b-) cells, anti-Fy6 binds to a molecule of apparent molecular
mass (by SDS-PAGE) in the same range as the protein immunoprecipitated with
a strong anti-Fya alloantibody from Fya+ red cells (1) . This glycoprotein separates
as a rather broad band (Fig . 2) within which several sharper bands may be
visualized, the strongest of which appears to be 46 kD . Identical results were
obtained with Fy(a+b+) and Fy(ab+) red cells, but no binding of the anti-Fy6
monoclonal reagent was detectable on blots from Fy(ab- ) cells .
Duffy Types and Malaria Susceptibility ofNonhuman Primates.
￿
Tests ofnonhu-
man primates indicated not only that Fy6 differs from previously recognized
Duffy specificities but that the presence of Fy6 coincides with susceptibility of
red cells to invasion by P. vivax. This is summarized in Table III, which includes
pertinent references . Anti-Fy6 was negative withred cells of two Macaque species,
both of which were positive with anti-Fy b and anti-Fy3, and of Papio, which was
also positive, albeit weakly, with anti-Fya . The opposite pattern, positive reactions
with anti-Fy6 but reportedly negative with both anti-Fy
a and anti-Fyb, was
observed with the New World monkey Saimiri . Fy6 and Fyb , which are similar
in serological behavior and sensitivity to enzymes, may be present independently
of each other or together, but either or both are associated with the presence of
Fy3 in each species thus far studied . From these available though limited
observations, Fy3 might be thought of as, perhaps, the "older" specificity of the
system . Be this as it may, the data are important in assessing the possible
significance of the Fy6 epitope in the susceptibility of red cells to invasion by
malarial parasites . As shown in Table III, the New World monkey species whose
erythrocytes can be invaded by P. knowlesi are Fy(ab-) but Fy6' . On the other
hand, Old World monkeys, whose red cells are Fyb+ and are susceptible to P.
knowlesi lack theFy6 specificityand are not invaded in vitro byP. vivax, suggesting
that the precise Duffy epitope used by this parasite is distinct from that used by
P . knowlesi . These relations become more obvious when contingency analysis is
applied . Ifman is divided into two categories, Duffy positiveand Duffy negative,
the evaluated nonhuman primates provide seven additional categories, only three
of which are positive both for Fy6 and susceptibility to invasion by P. vivax
merozoites . Analyzed by Fisher's exact method, the probability of lack of asso-
ciation is p < 0.008 (126:1) . In distinction, the presence or absence of Fya, Fyb ,
and/or Fy3 cannot correspond to P. vivax susceptibility because rhesus, cynom-
olgous, squirrel, and capuchin are exceptional . Fy
a , Fyb , and/or Fy3, however,
correspond well with susceptibility to P . knowlesi, where of ten categories, only
capuchin is exceptional .
Summary
A new Duffy specificity, Fy6, defined by a murine monoclonal antibody of the
IgGIK class, is related to susceptibility to malarial invasion . In humans, Fy6 is
present on the red cells of all persons except those of the Fy(a-b- ) type, a
distribution resembling that of Fy3 . However proteolytic enzyme treatment of
red cells enhances the reactivity of Fy3, whereas Fy6, like Fya and Fyb , is
susceptible to degradation by this process . The number of Fy6 sites on human
red cells was found to be 12,200 per cell, in closeagreement with earlier estimates
of the number of Fya sites . Anti-Fy6 reacted in western blots with a membrane78 4
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glycoprotein of ^-46,000 M,., not significantly different from that of a molecule
known to bear the Fya determinant. The Fy6 epitope is shown to be present on
the red cells of some but not all nonhuman primate species, where it has a
distribution not only distinctly different from Fya, Fyb, and Fy3, but in close
accordance with susceptibility to penetration by Plasmodium vivax. Thus, the red
cells of two species o£ macaques (Macaca mulatta and M. fascicularis), which are
invaded by Plasmodium knowlesi but not by P. vivax are shown to have other
Duffy antigens but to be devoid of Fy6. It appears, therefore, that the red cell
epitopes used by these closely related species are distinct, and that susceptibility
to P. vivax merozoite penetration is dependent on the presence of Fy6.
We thank Dr. A. Rowe for providing several samples of nonhuman primate red cells, Dr.
W. L. Marsh for samples of rare human red cell types and a generous supply of the rare
anti-Fy3 serum, Ms. Tellervo Huima for photography, and Ms. A. Varipapa for her
expert manuscript preparation.
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